News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,353 Results
Type
Article (40498)
Company Profile (265)
Press Release (672583)
Multimedia
Podcasts (72)
Webinars (17)
Section
Business (204505)
Career Advice (2017)
Deals (35485)
Drug Delivery (100)
Drug Development (81256)
Employer Resources (173)
FDA (16320)
Job Trends (14922)
News (345976)
Policy (32684)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (116)
Alliances (49575)
ALS (134)
Alzheimer's disease (1558)
Antibody-drug conjugate (ADC) (221)
Approvals (16421)
Artificial intelligence (397)
Autoimmune disease (82)
Automation (29)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (151)
Biotechnology (175)
Bladder cancer (131)
Brain cancer (45)
Breast cancer (488)
Cancer (3822)
Cardiovascular disease (310)
Career advice (1699)
Career pathing (33)
CAR-T (225)
CDC (42)
Cell therapy (604)
Cervical cancer (31)
Clinical research (68200)
Collaboration (1309)
Company closure (4)
Compensation (915)
Complete response letters (43)
COVID-19 (2679)
CRISPR (73)
C-suite (563)
Cystic fibrosis (129)
Data (4637)
Decentralized trials (2)
Denatured (23)
Depression (93)
Diabetes (422)
Diagnostics (6537)
Digital health (33)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (184)
Drug pricing (157)
Drug shortages (28)
Duchenne muscular dystrophy (192)
Earnings (88939)
Editorial (46)
Employer branding (21)
Employer resources (151)
Events (115435)
Executive appointments (925)
FDA (18768)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1190)
Gene editing (159)
Generative AI (31)
Gene therapy (481)
GLP-1 (870)
Government (4602)
Grass and pollen (6)
Guidances (368)
Healthcare (18856)
HIV (43)
Huntington's disease (36)
IgA nephropathy (59)
Immunology and inflammation (208)
Immuno-oncology (17)
Indications (57)
Infectious disease (2902)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (92)
Intellectual property (188)
Interviews (315)
IPO (16612)
IRA (48)
Job creations (3639)
Job search strategy (1427)
Kidney cancer (15)
Labor market (73)
Layoffs (534)
Leadership (28)
Legal (7937)
Liver cancer (85)
Longevity (11)
Lung cancer (551)
Lymphoma (262)
Machine learning (29)
Management (59)
Manufacturing (589)
MASH (134)
Medical device (13625)
Medtech (13649)
Mergers & acquisitions (19753)
Metabolic disorders (1037)
Multiple sclerosis (133)
NASH (16)
Neurodegenerative disease (200)
Neuropsychiatric disorders (49)
Neuroscience (2515)
NextGen: Class of 2025 (6517)
Non-profit (4493)
Now hiring (59)
Obesity (485)
Opinion (239)
Ovarian cancer (136)
Pain (152)
Pancreatic cancer (167)
Parkinson's disease (226)
Partnered (28)
Patents (403)
Patient recruitment (320)
Peanut (52)
People (58244)
Pharmaceutical (63)
Pharmacy benefit managers (25)
Phase I (21229)
Phase II (30010)
Phase III (22385)
Pipeline (2721)
Policy (247)
Postmarket research (2564)
Preclinical (9042)
Press Release (64)
Prostate cancer (191)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (604)
Real estate (5936)
Recruiting (69)
Regulatory (23489)
Reports (51)
Research institute (2352)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (67)
Schizophrenia (126)
Series A (193)
Series B (148)
Service/supplier (11)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (35)
Startups (3600)
State (2)
Stomach cancer (14)
Supply chain (94)
Tariffs (79)
The Weekly (47)
Vaccines (905)
Venture capital (63)
Weight loss (315)
Women's health (55)
Worklife (17)
Date
Last 7 days (735)
Last 30 days (2462)
Last 365 days (30382)
2025 (25236)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54085)
2019 (46539)
2018 (35018)
2017 (32110)
2016 (31481)
2015 (37552)
2014 (31321)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (728)
Alabama (71)
Alaska (7)
Arizona (270)
Arkansas (13)
Asia (38686)
Australia (6324)
California (9314)
Canada (2843)
China (860)
Colorado (389)
Connecticut (397)
Delaware (262)
Europe (83328)
Florida (1394)
Georgia (301)
Hawaii (2)
Idaho (60)
Illinois (718)
India (48)
Indiana (451)
Iowa (18)
Japan (321)
Kansas (119)
Kentucky (34)
Louisiana (18)
Maine (68)
Maryland (1218)
Massachusetts (6783)
Michigan (283)
Minnesota (538)
Mississippi (4)
Missouri (111)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (72)
New Jersey (2565)
New Mexico (28)
New York (2522)
North Carolina (1253)
North Dakota (8)
Northern California (4347)
Ohio (285)
Oklahoma (20)
Oregon (37)
Pennsylvania (1957)
Puerto Rico (19)
Rhode Island (43)
South America (1099)
South Carolina (49)
South Dakota (1)
Southern California (3579)
Tennessee (148)
Texas (1438)
United States (33719)
Utah (276)
Virginia (221)
Washington D.C. (77)
Washington State (773)
West Virginia (4)
Wisconsin (79)
Wyoming (1)
713,353 Results for "cytokinetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Cytokinetics Soars on Aficamten’s ‘Best-in-Class’ Performance in Phase III Cardio Study
Data from the late-stage MAPLE-HCM study position Cytokinetics’ cardiac myosin inhibitor aficamten as a potential first-line therapy for patients with obstructive hypertrophic cardiomyopathy.
September 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cytokinetics to Announce Third Quarter Results on November 5, 2025
October 22, 2025
·
3 min read
Press Releases
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
September 23, 2025
·
3 min read
Press Releases
Cytokinetics to Participate in September 2025 Investor Conferences
August 28, 2025
·
3 min read
Press Releases
Cytokinetics Names Jim Daly to Board of Directors
August 20, 2025
·
3 min read
Press Releases
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
September 25, 2025
·
5 min read
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - October 17, 2025
October 20, 2025
·
4 min read
Press Releases
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
October 31, 2025
·
8 min read
Press Releases
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
September 30, 2025
·
12 min read
Press Releases
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
September 18, 2025
·
6 min read
1 of 71,336
Next
